医学资料
资源详情
- 文件数量
- 916
- 文件大小
- 62.00 GiB
- 收录时间
- 2026-10-10 00:13:24
- 最近发现
- 2026-10-10 00:13:14
- 资源类型
- 其他
- 扩展名
- avi,f4v,txt
- 种子哈希
- F85D7D855784D1AABC5F28B78A1EC68AAC5183A9
磁力链接
文件列表 共 916 个文件
文件路径大小
▧ Pathology/Section 3/Path_Cone_Ch24c_FibrocysticChanges.f4v28.61 MiB
▧ Pathology/Section 3/Path_Cone_Ch26c_HypoThyroidism.f4v26.94 MiB
▧ Pathology/Section 3/Path_Cone_Ch29c_MyasythenicSynd.f4v26.40 MiB
▧ Pathology/Section 3/Path_Cone_Ch27d_Osteoporosis_.f4v24.94 MiB
▧ Pathology/Section 3/Path_Cone_Ch24f_OtherBreastCond.f4v23.65 MiB
▧ Pathology/Section 3/Path_Cone_Ch27a_NormalBone.f4v23.48 MiB
▧ Pathology/Section 3/Path_Cone_Ch24d_BenignNeoplasms.f4v21.73 MiB
▧ Pathology/Section 3/Path_Cone_Ch26i_MultiEndocrineNeoSynd.f4v21.15 MiB
▧ Pathology/Section 3/Path_Cone_Ch26a_ThyroidGland.f4v20.30 MiB
▧ Pathology/Section 3/Path_Cone_Ch28c_SeroNegSpondy.f4v19.05 MiB
▧ Pathology/Section 3/Path_Cone_Ch28e_InfectiousArthritis.f4v19.02 MiB
▧ Pathology/Section 3/Path_Cone_Ch27e_Oesteomalacia.f4v15.96 MiB
▧ Pathology/Section 3/Path_Cone_Ch29b_InflammMyopathies.f4v14.80 MiB
▧ Pathology/Section 3/Path_Cone_Ch24b_Mastitis.f4v14.21 MiB
▧ Pathology/Section 3/Path_Cone_Ch28f_NeuroArthropathy_.f4v10.85 MiB
▧ Pathology/Section 3/Path_Cone_Ch29e_InflammNeuropathy.f4v10.31 MiB
▧ Pathology/Section 3/Path_Cone_Ch29a_SkeletalMuscle.f4v8.10 MiB
▧ Pathology/Section 3/Path_Cone_Ch24a_OverviewBreastPath.f4v5.60 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch02b_drCurves.f4v103.03 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch01b_Permeation.f4v94.69 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch01e_Biotransformation.f4v81.91 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch02d_Signaling.f4v79.24 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch01d_Distribution.f4v78.67 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch01f_Elimination.f4v58.07 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch01g_SteadyState.f4v47.89 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch01c_Absorbtion.f4v41.97 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch02e_DrugDevelopment.f4v22.77 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch01a_Pharmokinetics.f4v17.10 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch02c_Quantal.f4v16.19 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch02a_Pharmadynamics.f4v11.46 MiB
▧ Pharmacology/Section 1 - General Principles/Pharm1_Sec01_Ch01h_Calculations.f4v9.87 MiB
▧ Pharmacology/Section 10 - Immunopharmacology/Pharm_10_Raymon_Ch01d_Monoclonal.f4v15.49 MiB
▧ Pharmacology/Section 10 - Immunopharmacology/Pharm_10_Raymon_Ch01a_Cyclosporine.f4v13.91 MiB
▧ Pharmacology/Section 10 - Immunopharmacology/Pharm_10_Raymon_Ch01e_Cytokines.f4v5.71 MiB
▧ Pharmacology/Section 10 - Immunopharmacology/Pharm_10_Raymon_Ch01c_AntiDImmunol.f4v3.94 MiB
▧ Pharmacology/Section 10 - Immunopharmacology/Pharm_10_Raymon_Ch01b_Azathioprine.f4v3.52 MiB
▧ Pharmacology/Section 11 - Toxicology/Pharm1_Sec11_Ch01a_CommonToxic.f4v41.09 MiB
▧ Pharmacology/Section 11 - Toxicology/Pharm1_Sec11_Ch01b_HeavyMetal.f4v30.14 MiB
▧ Pharmacology/Section 11 - Toxicology/Pharm1_Sec11_Ch01c_Antidotes.f4v13.69 MiB
▧ Pharmacology/Section 11 - Toxicology/Pharm1_Sec11_Ch01d_NaturalMed.f4v12.04 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch02b_MuscarinicRecepActivat.f4v247.62 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch04b_ANSPracticeProblems_02.f4v217.81 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch03a_CatecholaminSynActionDegradation.f4v197.68 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch03b_DirectActAdrenoceptorAgonists.f4v190.83 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch02a_CholinericNeuroJunction.f4v175.19 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch01b_BloodPresureConMech.f4v150.88 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch04b_ANSPracticeProblems_01.f4v130.23 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch03e_BetaReceptorAntagonists.f4v128.97 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch01a_AnatomyANS.f4v108.15 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch02c_Muscarinic_RecepAntagonists.f4v82.03 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch01c_PupillarySizeAccomodation_1.f4v73.42 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch03d_AlphaRecepAntagonists.f4v60.53 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch04a_GlaucomaTreatment.f4v53.35 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch02d_NIcotinicRecepAntagonists.f4v51.65 MiB
▧ Pharmacology/Section 2 - Autonomic Pharmacology/Pharm01_Raymon_Sec02_Ch03c_IndirectActAdreenergicRecepAgnonists.f4v40.14 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch02a_NA_ChanneLBlockers.f4v140.24 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch04b_Inotropes.f4v123.20 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch01a_CardiacActionPotential.f4v109.36 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch03b_DrugsAlteringSympatheticAct.f4v99.04 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch06d_LoopDiuretics.f4v98.71 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch06c_CarbonicAnhydraseInhibitors.f4v83.68 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch05c_CCBs_BetaBlockers_Carvedilol.f4v57.55 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch03c_DirectActing_Vasodialators.f4v56.41 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch03f_AngiotensinConvertingInhibitors.f4v55.53 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch06a_Diuretics.f4v54.98 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch06e_Thiazides.f4v52.47 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch02e_Unclassified.f4v51.48 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch01b_NA_Channels.f4v50.88 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch04a_TheFailingHeart.f4v50.83 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch02c_K_ChannelBlockers.f4v46.58 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch06f_K_-SparingAgents.f4v43.24 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch05b_Nitrates.f4v38.98 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch03a_DrugsStrategy.f4v38.09 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch07b_HMG-CoA_Reductase_Inhibitors.f4v36.09 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch07a_Antihyperlipidemics.f4v33.24 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch03h_TreatmentOfPulmonaryHyptension.f4v27.61 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch03d_CalciumChannelBlockers.f4v23.99 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch02d_Ca_ChannelBlockers.f4v22.37 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch06b_OsmoticDiuretics.f4v19.84 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch07e_Gemfibrozil.f4v19.22 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch07c_Bile_and_Sequestrants.f4v16.55 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch07d_Nicotine_Acid_Niacin.f4v13.67 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch05a_RationaleForUse.f4v13.00 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch03g_IndicatonsForUseOfAntihypertensive.f4v10.85 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch02b_Beta_Blockers.f4v10.82 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch04C_OtherDrugs.f4v10.45 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch07g_Orlistat.f4v7.40 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch07f_Ezetimbe.f4v6.22 MiB
▧ Pharmacology/Section 3 - Cardiac & Renal Pharmacology/Pharm01_Raymon_Sec03_Ch03e_Diuretics.f4v868.61 KiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch01a_SedativeHynoticAnxiolyticDrugs.f4v297.47 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch05a_OpioidAnalgesics.f4v226.97 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch03a_Anticonvulsants.f4v192.40 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch06d_AntipsychoticDrugs.f4v178.53 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch06c_DrugUsedInParkinsonDisease.f4v145.01 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch07a_DrugsUsedInDepression.f4v142.41 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch04a_GeneralAnesthesia.f4v125.14 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch02a_Alcohols.f4v108.22 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch04c_SkeletalMuscleRelaxants.f4v103.12 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch08a_DrugsOfAbuse.f4v100.19 MiB
▧ Pharmacology/Section 4 - CNS Pharmacology/Pharm01_Raymon_Sec04_Ch04b_LocalAnesthesia.f4v94.09 MiB
友情提示
本站只提供公开网络中的资源元数据信息，不存储资源文件，也不提供下载服务。请遵守当地法律法规并尊重内容版权。